A. Bechara et al., PROSTAGLANDIN-E1 VERSUS MIXTURE OF PROSTAGLANDIN-E1, PAPAVERINE AND PHENTOLAMINE IN NONRESPONDERS TO HIGH PAPAVERINE PLUS PHENTOLAMINE DOSES, The Journal of urology, 155(3), 1996, pp. 913-914
Purpose: We evaluated the efficacy of 40 mu g./ml. prostaglandin E1 ve
rsus a combination of 17.64 mg./ml. papaverine hydrochloride, 0.58 mg.
/ml. phentolamine mesylate and 5.8 mu g./ml. prostaglandin E1 (3-drug
mixture). Materials and Methods: A total of 32 patients randomly recei
ved 1 ml. of either medication by the intracavernous route. All patien
ts had presented with erectile dysfunction longer than 6 months in dur
ation and had failed to respond to high doses of papaverine (60 mg.) p
lus phentolamine (1 mg.). Results: Of 32 patients 7 (22%) responded to
prostaglandin E1 and 16 (50%) to the S-drug mixture, achieving erecti
ons allowing penetration (grade E4 or E5, p <0.05). Pain was reported
by 41% of the patients receiving prostaglandin E1 and by 12.5% adminis
tered the 3-drug mixture. Conclusions: The 3-drug mixture may be regar
ded as more effective than prostaglandin E1 alone in inducing an erect
ile response with a decreased incidence of pain.